Clinical Trials Browser

Adenocarcinoma, Mucinous × Fluorouracil × 90 days × Clear all

NCT05504252 2026-01-07

METIMMOX-2

Phase 2 Active not recruiting

Adenocarcinoma, Mucinous, Carcinoma, Signet Ring Cell